Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...

AUSTIN, Texas, March 13, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) is pleased to announce a strategic partnership with a leading biotechnology company with a multi ...

The round, which Harbour described as a “series B+,” came shortly after the antibody specialist took ... rights to multiple drugs and raise an “A+” round before securing $85 million ...

Biotech companies are already beginning to recognize machine-learning’s potential to optimize the next-generation of therapeutic antibodies. “Some companies have developed antibodies that they ...

AUSTIN, Texas, February 20, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody ...